Jesse Vislisel, MD
Ophthalmology · Stillwater, MNNPI 1063704294
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,775 of the $4,145 with a category attached, or 66.9%. 11 manufacturers reported payments, led by Alcon at 50.6% of the total. Reporting peaked in 2019 at $2,551 and has fallen 99.2% since, to $20 in 2025.
Across 31 payments — averaging $133.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Johnson & Johnson Surgical Vision, Inc.$2K
- Alcon Research LLC$245
- Oyster Point Pharma, Inc.$88
- Topcon Healthcare Solutions, Inc.$80
- Ocular Therapeutix, Inc.$50
- plus $85 from 5 others
Across 137 payments — averaging $394.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$54K
What the payments were for
- Consulting fees$2,77567%
- Travel & lodging$63215%
- Food & beverage$73818%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 16 | $2,097 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $1,500 |
| Alcon Research LLC | 1 | $245 |
| Oyster Point Pharma, Inc. | 5 | $88 |
| Topcon Healthcare Solutions, Inc. | 1 | $80 |
| Ocular Therapeutix, Inc. | 1 | $50 |
| Johnson & Johnson Vision Care, Inc. | 2 | $30 |
| Harrow Eye, LLC | 1 | $20 |
| Tarsus Pharmaceuticals, Inc. | 1 | $15 |
| The Cameron-ehlen Group, Inc. | 1 | $13 |
| Biotissue Holdings Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis Symfony IOL$1,500
- AcrySof IQ VIVITY$980
- DAILIES$385
How this compares
$4,145 in reported general payments places this provider in the 85th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 22 | $26,047 |
| RestasisCyclosporine | 36 | $24,953 |
| Fluorometholone | 327 | $22,644 |
| Prednisolone Acetate | 514 | $22,403 |
| Restasis MultidoseCyclosporine | 12 | $11,529 |
| Cyclosporine | 11 | $8,871 |
| LumiganBimatoprost | 13 | $6,430 |
| MoxifloxacinMoxifloxacin Hcl | 215 | $4,758 |
| ValacyclovirValacyclovir Hcl | 114 | $4,371 |
| Latanoprost | 214 | $3,540 |
| Loteprednol Etabonate | 21 | $2,343 |
| Difluprednate | 26 | $2,168 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $2,026 |
| Timolol Maleate | 150 | $1,496 |
| Diclofenac Sodium | 92 | $1,353 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Stillwater
- Edwin RyanMinneapolis$9.6M
- Mark LobanoffSt Louis Park$6.3M
- Richard LindstromBloomington$5.6M
- Thomas SamuelsonMinnetonka$435K
- Deborah RistvedtAlexandria$392K
- Yun-Sen ChuBloomington$222K
- Sophie BakriRochester$183K
- David HardtenMinneapolis$119K
- John ChenRochester$82K
- Christine LarsenBloomington$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.